Advertisement

Diabetologia

, Volume 29, Issue 3, pp 142–145 | Cite as

Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man

  • Olcay Gedik
  • S. Akahn
Originals

Summary

We have studied the effects of vitamin D deficiency on pancreatic A- and B-cell function. Four subjects with vitamin D deficiency and 10 healthy subjects were studied. Pancreatic B-cell function was assessed by the insulin response to an oral glucose tolerance test. An insulin tolerance test was used to evaluate pancreatic A-cell function. The patients were then treated with 2000 U/day of vitamin D3 for 6 months, after which the clinical, metabolic, biochemical and radiological features of vitamin D deficiency resolved, and pancreatic A-and B-cell function was repeated. In the vitamin D-deficient subjects pre-treatment and post-treatment serum calcium levels (mean±SEM) were 2.22±0.01 mmol/l and 2.24±0.01 mmol/1 respectively, and 2.27 ± 0.02 mmol/l in healthy subjects (NS). The pre-treatment level of 1,25-dihydroxy vitamin D (1,25-(OH)2D) of 29.7 ± 3.3 pg/ml in the vitamin D deficient subjects rose to 70.3±10.3pg/ml after treatment (p < 0.05). The 1,25-(OH)2D level in the healthy subjects was 50.0 ± 13.7 pg/ml (p < 0.05 versus pre- and post-treatment values in the patients). Insulin secretion, calculated by the area under the insulin curve, was significantly lower before vitamin D3 treatment in the patients (9.09±0.7 mU × min,p<0.05) compared with the healthy subjects (11.9±0.5 mU × min) and post-treatment values of the patients with vitamin D deficiency (13.7 ± 0.5 mU x min). Similar changes were seen in the insulogenic indicesΔ I/ΔG). WhileΔI/ΔG was 1.71±0.4 (mean ± SEM) during vitamin D deficiency, it increased to 2.48±0.3 with vitamin D repletion. The insulogenic index in the healthy subjects was 2.68±0.3. The glucose areas were not significantly different. Insulin-induced glucagon secretion was similar in all instances. The results of this study suggest that vitamin D deficiency reduces pancreatic insulin secretion but it does not affect pancreatic A-cell function.

Key words

Vitamin D insulin glucagon secretion 

References

  1. 1.
    Norman AW (1979) Vitamin D: The calcium homeostatic steroid hormone. Academic, New York, pp 25–50Google Scholar
  2. 2.
    Haussler MR and Mc Cain T (1977) Basic and clinical concepts related to vitamin D metabolism and action. New Engl J Med 297: 974–983, 1041–1050PubMedCrossRefGoogle Scholar
  3. 3.
    De Luca HF and Schones HK (1976) Metabolism and mechanism of action of vitamin D. Ann Rev Biochem 45: 631–666CrossRefGoogle Scholar
  4. 4.
    Brumbaugh PF and Haussler MF (1973) Nuclear and cytoplasme receptors for 1,25 dihydroxy-cholecaleiferol in intestinal mucosa. Biophys Res Commun 51: 74–80CrossRefGoogle Scholar
  5. 5.
    Kream BE, Jose M, Yamada S and De Luca HF (1977) A specific high-affinity binding macromolecule for 1,25 dihydroxy vitamin D3 in fetal bone. Science 197: 1086–1088PubMedGoogle Scholar
  6. 6.
    Christakos S and Norman AW (1979) Studies on the mode of calciferol XVIII. Evidence for a specific high affinity binding protein for 1,25 dihydroxy vitamin D3 in chick kidney and pancreas. Biochem Biophys Res Commun 89: 56–63PubMedCrossRefGoogle Scholar
  7. 7.
    Stumpf WE, Sar M, Reid FA, Tanaka Y and De Luca HF (1979) Target cells for 1,25-dihydroxy vitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206: 1088–1190Google Scholar
  8. 8.
    Clark SA, Stumpf WE, Sar M, De Luca HF and Tanaka Y (1980) Target cells for 1,25-dihydroxy vitamin D3 in the pancreas. Cell Tiss Res 209: 515–520CrossRefGoogle Scholar
  9. 9.
    Haussler MR, Pike JM, Chandler JS, Manologas SC and Deftos LJ (1981) Molecular action of 1,25 dihydroxy vitamin D3. Ann NY Acad Sci 372: 502–505PubMedGoogle Scholar
  10. 10.
    Norman AW and Ross FP (1979) Vitamin D secosteroid: Unique molecules with both hormone possible membranophillic properties. Life Sci 24: 759–769PubMedCrossRefGoogle Scholar
  11. 11.
    Norman AW, Frankel BJ, Helt AM and Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823–825PubMedGoogle Scholar
  12. 12.
    Clark SA, Stumpf WE and Sar M (1981) Effect of 1.25 dihydroxy vitamin D3 on insulin secretion. Diabetes 30: 382–389PubMedGoogle Scholar
  13. 13.
    Chertow BS, Sivits WI, Baranettsky NG, Clark SA, Waite A and De Luca HF (1983) Cellular mechanism of insulin release; the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113: 1514–1548Google Scholar
  14. 14.
    Tanaka Y, Senie Y, Ishida M, Yamacha K, Yabuchi H, Ishida H, Seino Y and Imura H (1984) Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol 105: 528–533PubMedGoogle Scholar
  15. 15.
    Somogyi M (1945) Determination of blood sugar. J Biol Chem 160: 69–73Google Scholar
  16. 16.
    Manologas SC, Culler FL, Howard A, Brickman S and Deftos LJ (1983) The cytoreceptor assay for 1,25 dihydroxy vitamin D and its application to clinical studies. J Clin Endocrinol Metab 56: 751–760Google Scholar
  17. 17.
    Chiles R and Tzagournis M (1970) Excessive serum insulin response to oral glucose in obesity and mild diabetes. Diabetes 19: 458–464PubMedGoogle Scholar
  18. 18.
    Gibbons JD (1975) Nonparametric statistical inference. Mc Graw-Hill, New York, pp 133–158Google Scholar
  19. 19.
    Kodieck E, Lawson DEM and Wilson PW (1970) Biological activity of a polar metabolite of vitamin D3. Nature 228: 763–764CrossRefGoogle Scholar
  20. 20.
    Norman AW, Roth J and Orci L (1982) The vitamin D endocrine system: steroid metabolism hormone receptors and biological response (calcium binding proteins). Endocrinol Rev 3: 331–352CrossRefGoogle Scholar
  21. 21.
    Grodsky GM and Benett LL (1962) Cation requirements for insulin secretion in the isolated perfused pancreas. Diabetes 15: 910–912Google Scholar
  22. 22.
    Hellman B (1975) The significance of calcium for glucose stimulation of insulin release. Endocrinology 97: 392–398PubMedCrossRefGoogle Scholar
  23. 23.
    Gedik O and Zileli MS (1977) Effects of hypocalcemia and theophylline on glucose tolerance and insulin release in human beings. Diabetes 26: 813–819PubMedGoogle Scholar
  24. 24.
    Yasuda K, Hanikawa Y, Okuyama M, Kituchi M and Yoshinaga K (1975) Glucose tolerance and insulin secretion in patients with para-thyroid disorders. Effects of serum calcium on insulin release. New Engl J Med 292: 501–504PubMedCrossRefGoogle Scholar
  25. 25.
    Schobach D, Tatcher J, Leombruno R and Brown E (1983) Effects of extracellular Ca++ and Mg++ on cytosolic Ca++ and PTH release in dispersed bovine parathyroid cells. Endocrinology 113: 424–426Google Scholar
  26. 26.
    Rassmusen H, Fontaine O and Matsumoto T (1981) Liponomic regulation of calcium transport by 1.25 (OH)2 D3. Ann NY Acad Sci 372: 518–529Google Scholar
  27. 27.
    Drücke T, Lacour B, Lucas PA, Karsentry G and Mauriat F (1985) Rapid changes in enterocyt membrane phospholipid content and ion transport induced by 1,25-dihydroxyvitamin D3. Sixth Workshop on Vitamin D Abstracts. Academic, New York, pp 138Google Scholar
  28. 28.
    Kadowaki S and Norman AW (1985) Demonstration that the vitamin D metabolite 1,25-(OH)2 vitamin D3 and not 24 R. 25-(OH)2 Vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 34: 315–320PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • Olcay Gedik
    • 1
  • S. Akahn
    • 1
  1. 1.Department of Medicine, Section of EndocrinologyHacettepe Medical SchoolAnkaraTurkey

Personalised recommendations